These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24798725)

  • 1. Towards a personalized treatment in depression: endocannabinoids, inflammation and stress response.
    Zajkowska ZE; Englund A; Zunszain PA
    Pharmacogenomics; 2014 Apr; 15(5):687-98. PubMed ID: 24798725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
    Gorzalka BB; Hill MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1575-85. PubMed ID: 21111017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-related depression: neuroendocrine, genetic, and therapeutical aspects.
    Bosch OG; Seifritz E; Wetter TC
    World J Biol Psychiatry; 2012 Dec; 13(8):556-68. PubMed ID: 22676799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing is everything: evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic-pituitary-adrenal axis activity across developmental periods.
    Lee TT; Gorzalka BB
    Neuroscience; 2012 Mar; 204():17-30. PubMed ID: 22015924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids and stress.
    Riebe CJ; Wotjak CT
    Stress; 2011 Jul; 14(4):384-97. PubMed ID: 21663537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
    Binder EB; Salyakina D; Lichtner P; Wochnik GM; Ising M; Pütz B; Papiol S; Seaman S; Lucae S; Kohli MA; Nickel T; Künzel HE; Fuchs B; Majer M; Pfennig A; Kern N; Brunner J; Modell S; Baghai T; Deiml T; Zill P; Bondy B; Rupprecht R; Messer T; Köhnlein O; Dabitz H; Brückl T; Müller N; Pfister H; Lieb R; Mueller JC; Lõhmussaar E; Strom TM; Bettecken T; Meitinger T; Uhr M; Rein T; Holsboer F; Muller-Myhsok B
    Nat Genet; 2004 Dec; 36(12):1319-25. PubMed ID: 15565110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity.
    Cota D
    J Neuroendocrinol; 2008 May; 20 Suppl 1():35-8. PubMed ID: 18426497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.
    Gorzalka BB; Hill MN; Hillard CJ
    Neurosci Biobehav Rev; 2008 Aug; 32(6):1152-60. PubMed ID: 18433869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression.
    Kunugi H; Hori H; Adachi N; Numakawa T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):447-59. PubMed ID: 20923424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis.
    Steiner MA; Wotjak CT
    Prog Brain Res; 2008; 170():397-432. PubMed ID: 18655899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and genetic factors in stress-resilient and -vulnerable rats: a cross-fostering study.
    Uchida S; Hara K; Kobayashi A; Otsuki K; Hobara T; Yamagata H; Watanabe Y
    Brain Res; 2010 Feb; 1316():43-50. PubMed ID: 19962370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism of the antidepressant effect of 3,6'-disinapoyl sucrose from Polygala tenuifolia Willd.
    Hu Y; Liu M; Liu P; Guo DH; Wei RB; Rahman K
    J Pharm Pharmacol; 2011 Jun; 63(6):869-74. PubMed ID: 21585386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?
    Aznar S; Knudsen GM
    J Alzheimers Dis; 2011; 23(2):177-93. PubMed ID: 21098983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids and glucocorticoids modulate emotional memory after stress.
    Akirav I
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2554-63. PubMed ID: 23954749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.